MiMedx Group (MDXG) Competitors $7.31 +0.28 (+3.98%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$7.30 0.00 (-0.07%) As of 08/22/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MDXG vs. TMDX, NVST, LIVN, WRBY, INSP, PRCT, LMAT, EYE, AORT, and LQDAShould you be buying MiMedx Group stock or one of its competitors? The main competitors of MiMedx Group include TransMedics Group (TMDX), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), LeMaitre Vascular (LMAT), National Vision (EYE), Artivion (AORT), and Liquidia Technologies (LQDA). These companies are all part of the "medical equipment" industry. MiMedx Group vs. Its Competitors TransMedics Group Envista LivaNova Warby Parker Inspire Medical Systems PROCEPT BioRobotics LeMaitre Vascular National Vision Artivion Liquidia Technologies TransMedics Group (NASDAQ:TMDX) and MiMedx Group (NASDAQ:MDXG) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations. Do analysts recommend TMDX or MDXG? TransMedics Group currently has a consensus target price of $123.00, suggesting a potential upside of 2.63%. MiMedx Group has a consensus target price of $12.00, suggesting a potential upside of 64.16%. Given MiMedx Group's stronger consensus rating and higher probable upside, analysts clearly believe MiMedx Group is more favorable than TransMedics Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TransMedics Group 0 Sell rating(s) 3 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.78MiMedx Group 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better earnings and valuation, TMDX or MDXG? MiMedx Group has lower revenue, but higher earnings than TransMedics Group. MiMedx Group is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTransMedics Group$531.29M7.69$35.46M$1.9362.10MiMedx Group$348.88M3.10$42.42M$0.2134.81 Does the media refer more to TMDX or MDXG? In the previous week, TransMedics Group had 3 more articles in the media than MiMedx Group. MarketBeat recorded 5 mentions for TransMedics Group and 2 mentions for MiMedx Group. MiMedx Group's average media sentiment score of 1.77 beat TransMedics Group's score of 1.56 indicating that MiMedx Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TransMedics Group 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive MiMedx Group 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do insiders & institutionals have more ownership in TMDX or MDXG? 99.7% of TransMedics Group shares are owned by institutional investors. Comparatively, 79.2% of MiMedx Group shares are owned by institutional investors. 7.0% of TransMedics Group shares are owned by insiders. Comparatively, 1.7% of MiMedx Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Is TMDX or MDXG more profitable? TransMedics Group has a net margin of 13.49% compared to MiMedx Group's net margin of 8.84%. TransMedics Group's return on equity of 28.02% beat MiMedx Group's return on equity.Company Net Margins Return on Equity Return on Assets TransMedics Group13.49% 28.02% 8.64% MiMedx Group 8.84%23.03%17.09% Which has more volatility and risk, TMDX or MDXG? TransMedics Group has a beta of 2.09, meaning that its stock price is 109% more volatile than the S&P 500. Comparatively, MiMedx Group has a beta of 1.79, meaning that its stock price is 79% more volatile than the S&P 500. SummaryTransMedics Group beats MiMedx Group on 12 of the 17 factors compared between the two stocks. Get MiMedx Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MDXG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MDXG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDXG vs. The Competition Export to ExcelMetricMiMedx GroupMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.04B$3.11B$5.76B$9.58BDividend YieldN/A2.23%4.41%4.10%P/E Ratio34.8120.8831.1026.04Price / Sales3.10343.33433.45102.77Price / Cash21.2243.1937.7358.48Price / Book5.018.129.536.61Net Income$42.42M-$54.72M$3.26B$265.56M7 Day Performance2.81%2.63%2.10%1.97%1 Month Performance5.48%2.78%2.81%-0.36%1 Year Performance5.94%11.01%30.56%19.03% MiMedx Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDXGMiMedx Group3.2618 of 5 stars$7.31+4.0%$12.00+64.2%+11.1%$1.04B$348.88M34.81870Positive NewsTMDXTransMedics Group2.8635 of 5 stars$127.26+11.1%$123.00-3.3%-30.9%$3.90B$441.54M65.94210Positive NewsNVSTEnvista3.8499 of 5 stars$20.19-0.3%$20.92+3.7%+20.6%$3.36B$2.51B63.0812,300LIVNLivaNova1.736 of 5 stars$49.56+1.5%$59.29+19.6%+21.4%$2.67B$1.25B-12.742,900Positive NewsAnalyst ForecastWRBYWarby Parker2.1262 of 5 stars$23.25-0.4%$24.06+3.5%+94.9%$2.44B$771.32M-332.023,780Positive NewsAnalyst UpgradeINSPInspire Medical Systems4.9366 of 5 stars$79.62+0.6%$173.31+117.7%-48.6%$2.34B$802.80M46.021,246Positive NewsShort Interest ↓PRCTPROCEPT BioRobotics3.5514 of 5 stars$38.77+0.9%$74.88+93.1%-48.6%$2.14B$224.50M-25.01430LMATLeMaitre Vascular2.1996 of 5 stars$92.62+0.4%$98.00+5.8%+16.4%$2.09B$219.86M44.96490Positive NewsEYENational Vision2.8033 of 5 stars$22.77+0.6%$24.73+8.6%+142.5%$1.79B$1.82B-126.5213,411Positive NewsAORTArtivion3.5705 of 5 stars$43.05+5.1%$40.00-7.1%+75.6%$1.75B$388.54M-102.511,600Analyst ForecastInsider TradeHigh Trading VolumeLQDALiquidia Technologies3.5433 of 5 stars$21.20+3.7%$26.89+26.8%+178.7%$1.75B$14M-13.4250 Related Companies and Tools Related Companies TransMedics Group Alternatives Envista Alternatives LivaNova Alternatives Warby Parker Alternatives Inspire Medical Systems Alternatives PROCEPT BioRobotics Alternatives LeMaitre Vascular Alternatives National Vision Alternatives Artivion Alternatives Liquidia Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MDXG) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiMedx Group, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share MiMedx Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access